Skip to main content
Carasent logo

Carasent — Investor Relations & Filings

Ticker · CARA ISIN · NO0010123060 LEI · 5967007LIEEXZXI9ZS60 OL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 635 across all filing types
Latest filing 2024-11-29 Report Publication Anno…
Country NO Norway
Listing OL CARA

About Carasent

https://carasent.com/

Carasent is a health technology group focused on enhancing efficiency and quality in the healthcare sector. The company develops and provides mission-critical, cloud-based software solutions, with a primary focus on Electronic Health Record (EHR) and Electronic Medical Record (EMR) systems, often delivered as Software as a Service (SaaS). With over 30 years of experience, Carasent also offers a suite of integrated ecosystem services designed to automate and streamline clinical and administrative workflows. By integrating its core platforms with proprietary and third-party applications, the company creates seamless processes that reduce administrative burdens for customers in the healthcare, rehabilitation, and occupational health sectors.

Recent filings

Filing Released Lang Actions
Carasent AB (publ) offentliggör prospekt i samband med dess notering på Nasdaq Stockholm
Report Publication Announcement Classification · 98% confidence The document is a press release from Carasent AB announcing the publication of a prospectus in connection with its listing on Nasdaq Stockholm, following a cross-border merger. The text explicitly mentions that the prospectus has been approved by the Swedish Financial Supervisory Authority (Finansinspektionen) and is now available. This document is an announcement about the availability of a key legal/financial document (the prospectus) related to a corporate action (listing/merger), rather than the prospectus itself or a standard periodic report (like 10-K or IR). Since it is an announcement regarding the publication of a formal document, it fits best under 'Report Publication Announcement' (RPA), which covers announcements about the release or publication of company reports. It is not a general regulatory filing (RNS) because RPA is more specific for this context.
2024-11-29 Swedish
Carasent AB (publ) publishes prospectus in connection with its listing on Nasdaq Stockholm
Capital/Financing Update Classification · 95% confidence The document is a press release titled "Carasent AB (publ) publishes prospectus in connection with its listing on Nasdaq Stockholm." It explicitly mentions the publication and approval of a prospectus related to a cross-border merger and relisting on Nasdaq Stockholm. This activity—the issuance of a prospectus related to a significant corporate action (listing/merger)—falls under financing or capital structure changes. However, the core subject is the publication of the prospectus itself, which is a key document in capital raising or listing events. Since the document is an announcement about a prospectus being published, it relates closely to capital/financing activities. Given the options, 'Capital/Financing Update' (CAP) is the most appropriate fit as it covers fundraising and capital structure changes, which a listing prospectus announcement directly relates to. It is not a general regulatory filing (RNS) because it is highly specific to a financing event, nor is it a general earnings release (ER) or interim report (IR).
2024-11-29 English
Carasent AB (publ) offentliggör prospekt i samband med dess notering på Nasdaq Stockholm
Capital/Financing Update Classification · 95% confidence The document is a press release from Carasent AB announcing that it is publishing a prospectus ('prospekt') in connection with its listing on Nasdaq Stockholm, following a cross-border merger. The text explicitly mentions that the prospectus has been approved by the Swedish Financial Supervisory Authority ('Finansinspektionen'). This document is an announcement about the availability of a key regulatory/financing document (the prospectus) related to a listing/capital event, rather than the prospectus itself or a general earnings release. Since the core event is the publication of a prospectus related to a listing/capital structure change, and it is presented as a formal announcement, it aligns best with 'Capital/Financing Update' (CAP) or potentially 'Regulatory Filings' (RNS) if the financing aspect is secondary. However, the focus on the 'prospectus' and the 'listing' strongly suggests a capital market activity. Given the options, 'CAP' (Capital/Financing Update) is the most specific fit for an announcement detailing the publication of a prospectus for a listing, which is a major financing/capital structure event. It is not a standard 10-K, ER, or IR. It is an announcement, but the content is highly specific to capital markets, making CAP more precise than the general RPA or RNS.
2024-11-29 Swedish
Carasent AB (publ) publishes prospectus in connection with its listing on Nasdaq Stockholm
Capital/Financing Update Classification · 95% confidence The document is an announcement by Carasent AB (publ) regarding the publication of a prospectus in connection with its listing on Nasdaq Stockholm, following a cross-border merger. The text explicitly mentions the approval of the prospectus by the Swedish Financial Supervisory Authority and its availability. This document is not the full Annual Report (10-K), an Interim Report (IR), or a standard Earnings Release (ER). It is an announcement related to a significant corporate action involving capital structure/listing, which often involves the issuance of a prospectus. Since the core event is the listing/relisting and the document is an announcement about the prospectus, it relates closely to financing/capital structure changes. However, the most specific category for documents announcing the publication of official offering documents like prospectuses, especially those related to listing or significant capital events, is often best captured by 'Capital/Financing Update' (CAP) or, if it were purely an announcement of the report's release, 'Report Publication Announcement' (RPA). Given the context is a listing and the document is the prospectus announcement itself, CAP is highly relevant. Alternatively, since it is a formal regulatory document related to a listing, it could fall under 'Regulatory Filings' (RNS) if CAP is too broad. Reviewing the definitions, 'CAP' covers 'Updates on company fundraising, financing activities, or capital structure changes.' A listing prospectus announcement fits perfectly under financing activities/capital structure change. I will classify it as CAP, as it is more specific than RNS, and it is not just announcing a report but detailing a major financing/listing event.
2024-11-29 English
Carasent ASA - primary insider trading
Director's Dealing Classification · 99% confidence The document explicitly states 'primary insider trading' and details a transaction by a 'Chief Compliance Officer' (a senior executive/insider) involving the acquisition of shares. This directly corresponds to the definition of Director's Dealing (insider trades). Filing Code: DIRS.
2024-11-22 English
Carasent ASA - Carasent AB (publ) has been approved for listing on Nasdaq Stockholm
Delisting Announcement Classification · 99% confidence The document announces that Carasent AB (publ) has been approved for listing on Nasdaq Stockholm, subject to customary conditions, including prospectus approval. It details the timeline for a cross-border merger and the expected last day of trading on Oslo Børs and the first day of trading on Nasdaq Stockholm. This information pertains to a significant change in the company's capital structure and listing status, specifically related to the admission to trading of its shares on a new exchange following a merger. This fits best under 'Capital/Financing Update' (CAP) as it directly concerns the listing and exchange of shares following a corporate action (merger), or potentially 'Regulatory Filings' (RNS) if it were a general announcement. Given the focus on the listing approval and the mechanics of the share exchange resulting from the merger, CAP is the most specific fit, although it also touches upon listing mechanics which could sometimes fall under RNS. Since it is a direct announcement about the admission to trading and capital structure change resulting from the merger, CAP is chosen over the general RNS.
2024-11-08 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.